- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01296724
PREMAPIV : Intravesical Pressure Variation at Different Bladder Instillation Volumes in Newborn Children
November 25, 2013 updated by: Rennes University Hospital
Abdominal Compartment Syndrome (ASC) is defined by an Intra Abdominal Hypertension (IAH) associated with a new organ failure.
The occurrence of this syndrome is not well known in infants.
Preterm birth is frequently associated with gastrointestinal complications, particularly Necrotizing Enterocolitis.
In this pathology it is likely that the intra abdominal pressure (IAP) increases and can participate in the occurrence of organ failures.
Newborn, in particular with digestive malformation as diaphragmatic hernias, gastroschisis, could themselves be suffering from this syndrome.
It would be interesting to make early diagnosis in order to optimize the management of these children.
This requires reliable measurements methods and standards.
Intravesical Pressure (IVP) is the most reliable validated indirect method to measure intra-abdominal pressure.
In order to measure the IVP, the bladder must contain a minimum of liquid.
However, using inappropriate volumes could give erroneous IAP readings.
The optimal amount of saline to inject in older children, determined from pressure-volume curves study is 1 ml/kg.
In preterm and term infants, this volume appear extremely low (e.g.
0 8cc if taking a child to 800 g).
The question that arises is whether this quantity is sufficient to obtain reliable and reproducible measurements of IVP in preterm and term.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
54
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Brittany
-
Rennes, Brittany, France, 35203
- Rennes University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 3 months (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Preterm or term newborn admitted in paediatric intensive care unit
- With an urethral catheter
- Consent signed by parents
Exclusion Criteria:
- Weight > 4.5 kg
- Urinary tract or bladder pathology
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: newborn with digestive pathology
Preterm or term newborn admitted in paediatric intensive care unit with an urethral catheter and digestive pathology
|
For the installation of the urinary catheter, a valve connected to a pressure head is intercalated between the probe and the collecting bag.
Various Intravesical pressure measurements will be conducted after injection of 0 ml/kg, 0.5 ml/kg, 1 ml/kg, 1.5 ml/kg, 2 ml/kg, 2.5 ml/kg 3 ml/kg, 3.5 ml/kg and 4 ml/kg of physiological saline.
For the installation of the urinary catheter, a valve connected to a pressure head is intercalated between the probe and the collecting bag.
Various IVP measurements will be conducted after injection of 0 ml/kg, 0.5 ml/kg, 1 ml/kg, 1.5 ml/kg, 2 ml/kg, 2.5 ml/kg 3 ml/kg, 3.5 ml/kg and 4 ml/kg of physiological saline.
|
|
Other: Newborn without digestive pathology
Preterm or term newborn admitted in paediatric intensive care unit with an urethral catheter and without digestive pathology
|
For the installation of the urinary catheter, a valve connected to a pressure head is intercalated between the probe and the collecting bag.
Various Intravesical pressure measurements will be conducted after injection of 0 ml/kg, 0.5 ml/kg, 1 ml/kg, 1.5 ml/kg, 2 ml/kg, 2.5 ml/kg 3 ml/kg, 3.5 ml/kg and 4 ml/kg of physiological saline.
For the installation of the urinary catheter, a valve connected to a pressure head is intercalated between the probe and the collecting bag.
Various IVP measurements will be conducted after injection of 0 ml/kg, 0.5 ml/kg, 1 ml/kg, 1.5 ml/kg, 2 ml/kg, 2.5 ml/kg 3 ml/kg, 3.5 ml/kg and 4 ml/kg of physiological saline.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Determinate the optimal volume of saline injection in the bladder for measuring intravesical pressure in infants, with and without digestive pathology
Time Frame: 2 years
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Determine the normal intravesical pressure in critically ill children, with and without digestive pathology
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Olivier Tirel, Rennes University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2011
Primary Completion (Actual)
July 1, 2013
Study Registration Dates
First Submitted
February 14, 2011
First Submitted That Met QC Criteria
February 14, 2011
First Posted (Estimate)
February 15, 2011
Study Record Updates
Last Update Posted (Estimate)
November 26, 2013
Last Update Submitted That Met QC Criteria
November 25, 2013
Last Verified
November 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- 2010-A01346-33
- LOC/10-17
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intensive Care Unit Syndrome
-
University of MelbourneEnrolling by invitationICU Acquired Weakness | Intensive Care Unit Syndrome | Intensive Care Unit Acquired Weakness | Post Intensive Care Unit Syndrome | Post Intensive Care SyndromeAustralia
-
Indiana UniversityIndiana University HealthRecruitingPost Intensive Care Unit Syndrome | Intensive Care Unit Delirium | Intensive Care Acquired Cognitive Impairment | Virtual Reality Cognitive TrainingUnited States
-
University Hospital, BrestNot yet recruitingIntensive Care Unit SyndromeFrance
-
Zealand University HospitalNot yet recruitingPost-Intensive Care Syndrome (PICS) | Intensive Care Unit (ICU) Patients | Symptom Burden
-
Assistance Publique - Hôpitaux de ParisRecruitingIntensive Care Unit Syndrome | Pediatric Post-intensive Care SyndromeFrance
-
Medical Centre LeeuwardenCompletedCritical Illness | Intensive Care Unit Acquired Weakness | Post Intensive Care Unit SyndromeNetherlands
-
Hospital Felix BulnesCompletedMechanical Ventilation Complication | Intensive Care Unit Syndrome | Intensive Care Unit Acquired Weakness | Intensive Care Unit Delirium | Intensive Care NeuropathyChile
-
University of CalgaryCanadian Institutes of Health Research (CIHR)CompletedDelirium | Post Intensive Care Unit Syndrome | Intensive Care Unit Delirium | Post Intensive Care Unit Syndrome FamilyCanada
-
Hospital Ernesto DornellesUnknownPTSD | Depressive Symptoms | Anxiety Symptoms | Intensive Care Unit Syndrome | Post Intensive Care Unit SyndromeBrazil
-
Academisch Medisch Centrum - Universiteit van Amsterdam...ZonMw: The Netherlands Organisation for Health Research and Development; THE...Not yet recruitingSepsis | Critical Illness | Post Intensive Care Unit Syndrome | Intensive Care Unit Survivors | Microbiome Dysbiosis
Clinical Trials on Measure of intravesical pressure
-
CHU de Quebec-Universite LavalRecruiting
-
French Cardiology SocietyFrench Federation of CardiologyCompletedHeart Failure With Preserved Ejection Fraction (HFPEF) | Left Ventricular End Diastolic Pressure (LVEDP)France
-
Centre Hospitalier Departemental VendeeCompleted
-
Herlev HospitalCompletedIschemic Heart Disease | Biofeed Back Guided Stress ManagementDenmark
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceCompletedHeterozygous Carriers of Gitelman SyndromeFrance
-
University Hospital, GenevaTerminatedCoronary Artery Disease | Mitral Regurgitation | Mitral Valve Insufficiency | Coronary StenosisSwitzerland
-
Centre Hospitalier Intercommunal de Toulon La Seyne...Sainte-Anne Military Teaching HospitalRecruitingMacular DiseasesFrance
-
University Hospital, MontpellierTerminatedLocoregional AnesthesiaFrance
-
Szeged UniversityUnknownHealthy Subjects | COPD Patients | Semi-supine Echo (SSE) | Flow-mediated Vasodilatation (FMD) | High Sensitive C-reactive Protein (hsCRP)Hungary
-
Hospital Privado de Comunidad de Mar del PlataCompleted